CD34+CLDN5+ tumor associated senescent endothelial cells through IGF2-IGF2R signaling increased cholangiocellular phenotype in hepatocellular carcinoma
Xin-yu Zhu, Wenting Liu, Xiaojuan Hou, Chen Zong, Wei Yu, Zhemin Shen, Shuping Qu, Min Hui Tao, Meiling Xue, Dao-yu Zhou, Hao-ran Bai, Lu Gao, Jinghua Jiang, Qiudong Zhao, Lixin Wei, Xue Yang, Zhipeng Han, Li Zhang
Abstract
• Utilizing single-cell RNA sequencing technology, we have identified a distinct subset of tumor-associated senescent endothelial cells. • This study demonstrated that senescent endothelial cells increased the cholangiocellular phenotype within hepatocellular carcinoma. • This study reveals that the cross-talk between the senescent endothelial cells and mesenchymal stem cells fostered the tumor progression. • Senescent endothelial cells recruited mesenchymal stem cells into the tumor microenvironment via IGF2-IGF2R signaling. The heterogeneity of hepatocellular carcinoma (HCC) is linked to tumor malignancy and poor prognosis. Nevertheless, the precise mechanisms underlying the development of the cholangiocellular phenotype (CCA) within HCC remain unclear. Emerging studies support that the cross-talk among the host cells within tumor microenvironment (TME) sustains the cancer cell plasticity. This study sought to identify the specific cell types involved in the formation of CCA and to elucidate their functional roles in the progression of HCC. S ingle-cell RNA sequencing was employed to identify the specific cell types involved in the formation of CCA. Both in vitro and vivo analyses were used to identify the tumor-associated senescent ECs and investigate the function in TME. The diethylnitrosamine-induced model was utilized to investigate the interaction between senescent ECs and MSCs, aiming to elucidate their synergistic contributions to the progression of CCA. Using single-cell RNA sequencing, we identified a distinct senescent-associated subset of endothelial cells (ECs), namely CD34 + CLDN5 + ECs, which mainly enriched in tumor tissue. Further, the senescent ECs were observed to secrete IGF2, which recruited mesenchymal stem cells (MSCs) into the TME through IGF2R/MAPK signaling. In primary liver cancer model, MSCs exhibited a strong tumor-promoting effect, increasing the CCA and tumor malignancy after HCC formation. Interestingly, knockdown of IGF2R expression in MSCs inhibited the increase of CCA caused by MSCs in HCC. Meanwhile, it was revealed that MSCs released multiple inflammatory and trophic-related cytokines to enhance the cancer stem cell-like characteristics in HCC cells. Finally, we demonstrated that CEBPβ up-regulated IGF2 expression in tumor senescent ECs by combining with Igf2 -promtor-sequence. Together, our findings illustrated that tumor associated senescent ECs in HCC recruited the MSCs into TME, enhancing cancer stem cell (CSC)-like features of HCC cells and contributing to the CCA formation.